In most cases, ACD causes mild to moderate anemia. But if you also have a pre-existing type of anemia (such as iron ...
Medically reviewed by Richard N. Fogoros, MD Sometimes, people with iron deficiency anemia don't respond to treatment with iron supplementation and may go months to years with little to no improvement ...
Canada NewsWire MISSISSAUGA, ON, Nov. 12, 2024 MISSISSAUGA, ON, Nov. 12, 2024 /CNW/ - GSK announced today that Health Canada has approved Ojjaara (momelotinib) for the treatment o ...
Mississauga: GSK has announced that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or ...
Safety and efficacy results for SIMPLIFY-1 were based upon a subset of patients with moderate to severe anemia (haemoglobin <10 g/dL) at baseline. The efficacy of momelotinib in the treatment of ...